2021
DOI: 10.1080/20477724.2021.1985892
|View full text |Cite
|
Sign up to set email alerts
|

Opportunistic free-living amoebal pathogens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0
8

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 19 publications
(18 citation statements)
references
References 168 publications
0
10
0
8
Order By: Relevance
“…With the escalation in global warming and increasing global water shortages, it is likely that infections due to waterborne pathogens including free-living amoebae will rise, with many members of the public resorting to private storage tanks to house water, especially in the developing world [ 5 , 42 ]. Medicinal chemists have introduced a number of compounds that may be used to treat a variety of endoparasites; however, there are a limited number of compounds which are efficacious against free-living amoeba infections, for use as disinfectants or as therapy, due to factors such as the inability of the drugs to cross the blood–brain barrier, as well as the robust nature of the cyst stage of these amoebae and its ability to endure harsh conditions [ 12 , 13 ]. Furthermore, the pharmaceutical industry has not placed a high priority on the development of new antiparasitic treatments, as many parasitic infections occur in underdeveloped countries.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…With the escalation in global warming and increasing global water shortages, it is likely that infections due to waterborne pathogens including free-living amoebae will rise, with many members of the public resorting to private storage tanks to house water, especially in the developing world [ 5 , 42 ]. Medicinal chemists have introduced a number of compounds that may be used to treat a variety of endoparasites; however, there are a limited number of compounds which are efficacious against free-living amoeba infections, for use as disinfectants or as therapy, due to factors such as the inability of the drugs to cross the blood–brain barrier, as well as the robust nature of the cyst stage of these amoebae and its ability to endure harsh conditions [ 12 , 13 ]. Furthermore, the pharmaceutical industry has not placed a high priority on the development of new antiparasitic treatments, as many parasitic infections occur in underdeveloped countries.…”
Section: Discussionmentioning
confidence: 99%
“…Subsequently, the number of A. castellanii was assessed using a haemocytometer. The starting A. castellanii inoculum (5 × 10 5 ) was adjusted by enumerating with a haemocytometer and then used for several tests [ 12 , 13 ].…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…N. gruberi and N. fowleri are unicellular organisms living worldwide in freshwater environments ( De Jonckheere, 2004 ; Mull et al, 2013 ). N. gruberi is considered to be the best safe system to study the pathogenic “brain-eating amoeba” N. fowleri , which can infect people and cause primary amoebic meningoencephalitis (PAM), a rare but almost always fatal disease ( Mungroo et al, 2021 ). The genomes of these organisms suggest canonical aerobic metabolism, such as the employment of cytochromes and ubiquinone in the respiratory chain, as well as properties of anaerobic metabolism, such as Fe-hydrogenase ( Tsaousis et al, 2014 ), which is typically utilized in metabolic processes of organisms adapted to anaerobic conditions ( Fritz-Laylin et al, 2011 ; Herman et al, 2021 ).…”
Section: Introductionmentioning
confidence: 99%